Search by Drug Name or NDC
NDC 59651-0114-30 Febuxostat 80 mg/1 Details
Febuxostat 80 mg/1
Febuxostat is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is FEBUXOSTAT.
MedlinePlus Drug Summary
Febuxostat is used to treat gout in adults who were not treated successfully with or who are not able to take allopurinol (Aloprim, Zyloprim). Gout is a type of arthritis in which uric acid, a naturally occurring substance in the body, builds up in the joints and causes sudden attacks of redness, swelling, pain, and heat in one or more joints. Febuxostat is in a class of medications called xanthine oxidase inhibitors. It works by decreasing the amount of uric acid that is made in the body. Febuxostat is used to prevent gout attacks but not to treat them once they occur.
Related Packages: 59651-0114-30Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Febuxostat
Product Information
| NDC | 59651-0114 |
|---|---|
| Product ID | 59651-114_04f80eb2-8171-4e18-93e4-514440e84b75 |
| Associated GPIs | |
| GCN Sequence Number | 064830 |
| GCN Sequence Number Description | febuxostat TABLET 80 MG ORAL |
| HIC3 | C7A |
| HIC3 Description | HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS |
| GCN | 16809 |
| HICL Sequence Number | 036106 |
| HICL Sequence Number Description | FEBUXOSTAT |
| Brand/Generic | Generic |
| Proprietary Name | Febuxostat |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Febuxostat |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 80 |
| Active Ingredient Units | mg/1 |
| Substance Name | FEBUXOSTAT |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210741 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59651-0114-30 (59651011430)
| NDC Package Code | 59651-114-30 |
|---|---|
| Billing NDC | 59651011430 |
| Package | 30 TABLET in 1 BOTTLE (59651-114-30) |
| Marketing Start Date | 2023-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.50092 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | FEBUXOSTAT 80 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis